Clinical Trials Logo

Adenoviral Infection clinical trials

View clinical trials related to Adenoviral Infection.

Filter by:
  • Terminated  
  • Page 1

NCT ID: NCT03160339 Terminated - Clinical trials for Adenoviral Infection

A Study to Assess the Safety, Pharmacodynamics, and Immunogenicity of PXVX0047

Start date: May 1, 2017
Phase: Phase 1
Study type: Interventional

PXVX0047 (Adenovirus Type 4 and Type 7 Vaccine [A549 Cells], Live, Oral) is an investigational vaccine in development for the indication of active immunization against adenovirus infection. The primary goals of this Phase 1 study are to evaluate safety, pharmacodynamics (viral shedding), and immunogenicity of PXVX0047.